Suppr超能文献

[局限性肾癌患者行部分肾切除术的疗效:单中心2046例患者的20年经验]

[Efficacy of partial nephrectomy in patients with localized renal carcinoma: a 20-year experience of 2 046 patients in a single center].

作者信息

Zou X P, Ning K, Zhang Z L, Xiong L B, Peng Y L, Zhou Z H, Huang Y X, Luo X, Li J B, Dong P, Guo S J, Han H, Zhou F J

机构信息

Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Department of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2023 Mar 29;61(5):395-402. doi: 10.3760/cma.j.cn112139-20221002-00416.

Abstract

To analyze the long-term survival of patients with localized renal cell carcinoma after partical nephrectomy. The clinicopathological records and survival follow-up data of 2 046 patients with localized renal cell carcinoma, who were treated with partial nephrectomy from August 2001 to February 2021 in the Department of Urology, Sun Yat-sen University Cancer Center, were retrospectively analyzed. There were 1 402 males and 644 females, aged ((IQR)) 51 (19) years (range: 6 to 86 years). The primary end point of this study was cancer-specific survival. Survival curves were estimated using the Kaplan-Meier method, and the difference test was performed by Log-rank test. Univariate and multivariate Cox analysis were fitted to determine factors associated with cancer-specific survival. The follow-up time was 49.2 (48.0) months (range: 1 to 229 months), with 1 974 patients surviving and 72 dying. The median cancer-specific survival time has not yet been reached. The 5- and 10-year cancer specific survival rates were 97.0% and 91.2%, respectively. The 10-year cancer-specific survival rates for stage pT1a (=1 447), pT1b (=523) and pT2 (=58) were 95.3%, 81.8%, and 81.7%, respectively. The 10-year cancer-specific survival rates of patients with nuclear grade 1 (=226), 2 (=1 244) and 3 to 4 (=278) were 96.6%, 89.4%, and 85.5%, respectively. There were no significant differences in 5-year cancer-specific survival rates among patients underwent open, laparoscopic, or robotic surgery (96.7% 97.1% 97.5%, =0.600). Multivariate analysis showed that age≥50 years (=3.93, 95%: 1.82 to 8.47, <0.01), T stage (T1b T1a: =3.31, 95%: 1.83 to 5.99, <0.01; T2+T3 T1a: =2.88, 95%: 1.00 to 8.28, =0.049) and nuclear grade (G3 to 4 G1: =2.81, 95%: 1.01 to 7.82, =0.048) were independent prognostic factors of localized renal cell carcinoma after partial nephrectomy. The long-term cancer-specific survival rates of patients with localized renal cancer after partial nephrectomy are satisfactory. The type of operation (open, laparoscopic, or robotic) has no significant effect on survival. However, patients with older age, higher nuclear grade, and higher T stage have a lower cancer-specific survival rate. Grasping surgical indications, attaching importance to preoperative evaluation, perioperative management, and postoperative follow-up, could benefit achieving satisfactory long-term survival.

摘要

分析局限性肾细胞癌患者行部分肾切除术后的长期生存情况。回顾性分析2001年8月至2021年2月在中山大学肿瘤防治中心泌尿外科接受部分肾切除术的2046例局限性肾细胞癌患者的临床病理记录和生存随访数据。其中男性1402例,女性644例,年龄(四分位间距)为51(19)岁(范围:6至86岁)。本研究的主要终点是癌症特异性生存。采用Kaplan-Meier法估计生存曲线,通过Log-rank检验进行差异检验。进行单因素和多因素Cox分析以确定与癌症特异性生存相关的因素。随访时间为49.2(48.0)个月(范围:1至229个月),1974例患者存活,72例死亡。癌症特异性生存时间中位数尚未达到。5年和10年癌症特异性生存率分别为97.0%和91.2%。pT1a期(=1447例)、pT1b期(=523例)和pT2期(=58例)的10年癌症特异性生存率分别为95.3%、81.8%和81.7%。核分级为1级(=226例)、2级(=1244例)和3至4级(=278例)的患者10年癌症特异性生存率分别为96.6%、89.4%和85.5%。接受开放手术、腹腔镜手术或机器人手术患者的5年癌症特异性生存率无显著差异(96.7%、97.1%、97.5%,P = 0.600)。多因素分析显示,年龄≥50岁(P = 3.93,95%置信区间:1.82至8.47,P < 0.01)、T分期(T1b比T1a:P = 3.31,95%置信区间:1.83至5.99, P < 0.01;T2 + T3比T1a:P = 2.88, 95%置信区间:1.00至8.28, P = 0.049)和核分级(G3至4比G1:P = 2.81, 95%置信区间:1.01至7.82, P = 0.048)是部分肾切除术后局限性肾细胞癌的独立预后因素。局限性肾癌患者行部分肾切除术后长期癌症特异性生存率令人满意。手术方式(开放、腹腔镜或机器人手术)对生存无显著影响。然而,年龄较大、核分级较高和T分期较高的患者癌症特异性生存率较低。掌握手术适应证、重视术前评估、围手术期管理和术后随访,有助于实现满意长期生存。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验